SELLAS Life Sciences Group, Inc. (SLS)
(Delayed Data from NSDQ)
$1.62 USD
+0.03 (1.89%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $1.63 +0.01 (0.62%) 7:40 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
SLS 1.62 +0.03(1.89%)
Will SLS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SLS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SLS
SELLAS Life Sciences Group (SLS) Upgraded to Buy: What Does It Mean for the Stock? (Revised)
Galena Biopharma (SLS) Upgraded to Buy: What Does It Mean for the Stock?
SLS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Galena Biopharma (SLS) Upgraded to Buy: Here's Why
Other News for SLS
Vanguard Group Inc's Strategic Acquisition in SELLAS Life Sciences Group Inc
Maxim Increases Price Target for Sellas Life Sciences (SLS) | SLS Stock News
Sellas Life Sciences price target raised by $3 at Maxim, here's why
SLS Stock: Maxim Group Raises Price Target by 75% to $7.00 | SLS Stock News
SELLAS Life Sciences (SLS) Rises on Promising AML Trial Results